文献速递帕金森病与运动障碍认知障碍与痴呆

快速眼动睡眠行为障碍预测帕金森病的运动进展和认知下降

REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
PubMed 文献 · Neurology · 2018-08-08

本研究纳入421例早期未用药帕金森病患者和196例无帕金森病对照,所有参与者接受[123I]FP-CIT SPECT、脑脊液评估、3T MRI和全面临床评估。在60个月随访中,快速眼动睡眠行为障碍的存在与更快的运动进展(HR=1.368,95%CI=1.036-1.806;p=0.027)和认知下降(HR=1.794,95%CI=1.163-2.768;p=0.008)相关。

要点

  • 在帕金森病患者中,快速眼动睡眠行为障碍与更快的运动进展和认知下降相关。
  • 快速眼动睡眠行为障碍仅在具有低α-突触核蛋白和低[123I]FP-CIT摄取的患者中预测运动进展。
  • 快速眼动睡眠行为障碍仅在具有低β-淀粉样蛋白1-42和低α-突触核蛋白的患者中预测认知下降。

核心结论

  • 帕金森病中快速眼动睡眠行为障碍的存在与更大突触核蛋白和多巴胺能病理患者的更快的运动进展相关,以及与更大突触核蛋白和淀粉样蛋白病理患者的更高认知下降风险相关。
  • 研究结果为理解帕金森病的表型及其预后提供了重要方向。

研究设计与样本

  • 研究纳入421例早期未用药帕金森病患者和196例无帕金森病对照。
  • 所有参与者接受[123I]FP-CIT SPECT扫描、脑脊液评估、3特斯拉MRI和全面临床评估。

主要发现

  • 横断面分析中,伴有很可能快速眼动睡眠行为障碍的帕金森病患者(PD-RBD)相比不伴快速眼动睡眠行为障碍的帕金森病患者,脑脊液β-淀粉样蛋白1-42水平更低、总tau与β-淀粉样蛋白1-42比值更高、非运动症状负担更高,以及在处理速度、视空间功能和延迟识别记忆的神经心理测试中得分更差。
  • 纵向分析中,快速眼动睡眠行为障碍的存在与60个月随访期间更快的运动进展(HR=1.368,95%CI=1.036-1.806;p=0.027)和认知下降(HR=1.794,95%CI=1.163-2.768;p=0.008)相关。
  • 快速眼动睡眠行为障碍仅在具有低α-突触核蛋白水平和低纹状体[123I]FP-CIT摄取的患者中预测运动进展(HR=2.091,95%CI=1.116-3.918;p=0.021)。
  • 快速眼动睡眠行为障碍仅在具有低β-淀粉样蛋白1-42和低α-突触核蛋白水平的患者中预测认知下降(HR=2.810,95%CI=1.462-5.400;p=0.002)。
  • 在无帕金森病的对照人群中,快速眼动睡眠行为障碍的存在与认知下降或任何基线病理改变无关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether REM sleep behavior disorder (RBD) is associated with worse motor and cognitive decline in Parkinson disease (PD) METHODS: Four-hundred twenty-one drug-naive patients with early-stage PD and 196 controls without PD were included in this study. All participants underwent a [123I]FP-CIT SPECT scan, CSF assessment, 3-tesla MRI, and thorough clinical assessments. RESULTS: At cross-sectional analyses, patients with PD and probable RBD (PD-RBD) had lower CSF β-amyloid 1-42 (Aβ42) levels and higher total tau to Aβ42 CSF ratio, higher nonmotor symptoms burden, and worse scores on neuropsychological tests of processing speed, visuospatial functioning, and delayed recognition memory compared to patients with PD without RBD. At longitudinal analyses, the presence of RBD was associated with faster motor progression (hazard ratio [HR] = 1.368, 95% confidence Interval [CI] = 1.036-1.806; p = 0.027) and cognitive decline (HR = 1.794, 95% CI = 1.163-2.768; p = 0.008) over 60-month follow-up. The presence of RBD was a predictor for motor progression only in patients with PD who had both low α-synuclein levels and low [123I]FP-CIT uptake in the striatum (HR = 2.091, 95% CI = 1.116-3.918; p = 0.021) and a predictor for cognitive decline only in patients with PD who had both low Aβ42 and low α-synuclein levels (HR = 2.810, 95% CI = 1.462-5.400; p = 0.002). In the population of controls without PD, the presence of RBD was not associated with cognitive decline or any baseline pathologic changes. CONCLUSION: The presence of RBD in PD is associated with faster motor progression in patients with greater synuclein and dopaminergic pathology, and with higher risk of cognitive decline in patients with greater synuclein and amyloid pathology. Our findings provide an important direction toward understanding phenotypes and their prognosis in PD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Pagano G, De Micco R, Yousaf T, et al. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease. Neurology. 2018. PMID: 30089615. doi:10.1212/WNL.0000000000006134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。